Venus Remedies

Part of MojoOne Strategy

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE411B01019
NSEID: VENUSREM
BSEID: 526953
View on NSE | View on BSE

INR

881.65

16.75 (1.94%)

BSENSE

Mar 25

BSE+NSE Vol: 59.93 k

Access older stock analysis version

{
  "main_header": {
    "sid": 568580,
    "name": "Venus Remedies",
    "stock_name": "Venus Remedies",
    "full_name": "Venus Remedies Ltd",
    "name_url": "stocks-analysis/venus-remedies",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "881.65",
    "chg": 16.75,
    "chgp": "1.94%",
    "dir": 1,
    "prev_price": "864.90",
    "mcapval": "1,209.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526953,
    "symbol": "VENUSREM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE411B01019",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "59.93 k",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venus-remedies-568580-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venus-remedies-568580-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Venus Remedies Ltd Locks at Upper Circuit With 4.3% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3916154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VenusRemediesLt_stocks_hitting_upper_circuit_3916154.png",
        "date": "2026-03-25 12:00:08",
        "description": "At Rs 909.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5% on 25 Mar 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Upper Circuit at Rs 866.25: Is Venus Remedies Ltd's 5.0% Surge Driven by Conviction or Thin Liquidity?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-surges-to-upper-circuit-on-strong-buying-momentum-3910688",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VenusRemediesLt_stocks_hitting_upper_circuit_3910688.png",
        "date": "2026-03-24 14:00:09",
        "description": "At Rs 866.25, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5.0% on 24 Mar 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Venus Remedies Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/venus-remedies-ltd-is-rated-buy-by-marketsmojo-3909687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VenusRemediesLt_mojoScore_3909687.png",
        "date": "2026-03-24 10:10:29",
        "description": "Venus Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Venus Remedies Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3907943",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VenusRemediesLt_stocks_hitting_lower_circuit_3907943.png",
        "date": "2026-03-23 13:00:09",
        "description": "At Rs 824.85, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 5% on 23 Mar 2026, with unfilled sell orders and a frozen price, signalling a day of pronounced selling pressure in this micro-cap pharmaceutical stock."
      },
      {
        "title": "Venus Remedies Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-hits-upper-circuit-amid-strong-buying-pressure-3902630",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VenusRemediesLt_stocks_hitting_upper_circuit_3902630.png",
        "date": "2026-03-20 10:00:11",
        "description": "Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 20 Mar 2026, propelled by robust buying interest and a maximum daily gain of 2.76%. The stock’s performance outpaced both its sector and the broader Sensex, signalling renewed investor confidence after a brief correction phase."
      },
      {
        "title": "Venus Remedies Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3898987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VenusRemediesLt_stocks_hitting_lower_circuit_3898987.png",
        "date": "2026-03-18 15:00:06",
        "description": "Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 18 Mar 2026, hitting its lower circuit limit and registering a maximum daily loss of 5%. The stock’s sharp decline reflects a sudden shift in investor sentiment, marked by panic selling and a significant volume of unfilled supply."
      },
      {
        "title": "Venus Remedies Ltd Hits New 52-Week High of Rs.950, Marking Strong Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-hits-new-52-week-high-of-rs950-marking-strong-momentum-3896534",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VenusRemediesLt_priceRelatedfactors_3896534.png",
        "date": "2026-03-17 11:06:57",
        "description": "Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has surged to a new 52-week and all-time high of Rs.950, marking a significant milestone in its market performance. This achievement reflects strong momentum driven by robust financial results and sustained gains over recent sessions."
      },
      {
        "title": "Venus Remedies Ltd Hits All-Time High at Rs 950, Marking a Milestone in Pharmaceutical Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-hits-all-time-high-at-rs-950-marking-a-milestone-in-pharmaceutical-sector-3896044",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VenusRemediesLt_priceRelatedfactors_3896044.png",
        "date": "2026-03-17 09:32:58",
        "description": "Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.950 on 17 Mar 2026, underscoring its robust performance and sustained growth trajectory. The stock’s recent surge reflects strong fundamentals and consistent positive results over multiple quarters."
      },
      {
        "title": "Venus Remedies Ltd Gains 27.03%: 5 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-gains-2703-5-key-factors-driving-the-surge-3891214",
        "imagepath": "",
        "date": "2026-03-14 14:05:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 09:</strong> Stock surges 7.31% amid heavy buying, Sensex falls 1.91%</p>\n                    <p><strong>Mar 11:</strong> Hits upper circuit with nearly 10% gain, strong volume spike</p>\n                    <p><strong>Mar 12:</strong> New 52-week high at Rs.912, Mojo rating downgraded to Hold</p>\n                    <p><strong>Mar 13:</strong> Reaches all-time high Rs.946.1, upgraded back to Buy, but hits lower circuit amid profit booking</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.703.80</div></div>\n                    <div class=\"stat-item\"><di..."
      }
    ],
    "total": 366,
    "sid": "568580",
    "stock_news_url": "https://www.marketsmojo.com/news/venus-remedies-568580"
  },
  "announcements": [
    {
      "caption": "Social Media Post Pertaining To Transfer Of Physical Shares.",
      "datetime": "10-Mar-2026",
      "details": "Social media Post pertaining to Transfer of physical shares.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Of Information Received From Promoter Group Companies Regarding Merger.",
      "datetime": "02-Mar-2026",
      "details": "Disclosure.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jan-2026",
      "details": "Copy of newspaper publication of UFR as on 31st December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Venus Remedies Ltd has declared <strong>30%</strong> dividend, ex-date: 23 Sep 13",
          "dt": "2013-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Venus Remedies Ltd Locks at Upper Circuit With 4.3% Gain — Buyers Queue, Sellers Absent

2026-03-25 12:00:08

At Rs 909.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5% on 25 Mar 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Upper Circuit at Rs 866.25: Is Venus Remedies Ltd's 5.0% Surge Driven by Conviction or Thin Liquidity?

2026-03-24 14:00:09

At Rs 866.25, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5.0% on 24 Mar 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Venus Remedies Ltd is Rated Buy by MarketsMOJO

2026-03-24 10:10:29

Venus Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Venus Remedies Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight

2026-03-23 13:00:09

At Rs 824.85, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 5% on 23 Mar 2026, with unfilled sell orders and a frozen price, signalling a day of pronounced selling pressure in this micro-cap pharmaceutical stock.

Read full news article

Venus Remedies Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-20 10:00:11

Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 20 Mar 2026, propelled by robust buying interest and a maximum daily gain of 2.76%. The stock’s performance outpaced both its sector and the broader Sensex, signalling renewed investor confidence after a brief correction phase.

Read full news article

Venus Remedies Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-03-18 15:00:06

Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 18 Mar 2026, hitting its lower circuit limit and registering a maximum daily loss of 5%. The stock’s sharp decline reflects a sudden shift in investor sentiment, marked by panic selling and a significant volume of unfilled supply.

Read full news article

Venus Remedies Ltd Hits New 52-Week High of Rs.950, Marking Strong Momentum

2026-03-17 11:06:57

Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has surged to a new 52-week and all-time high of Rs.950, marking a significant milestone in its market performance. This achievement reflects strong momentum driven by robust financial results and sustained gains over recent sessions.

Read full news article

Venus Remedies Ltd Hits All-Time High at Rs 950, Marking a Milestone in Pharmaceutical Sector

2026-03-17 09:32:58

Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.950 on 17 Mar 2026, underscoring its robust performance and sustained growth trajectory. The stock’s recent surge reflects strong fundamentals and consistent positive results over multiple quarters.